Jacob Frenkel and Harvey Krueger Join Advisory Board of BrainStorm Cell Therapeutics Inc.
NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today the appointment of Dr. Jacob Frenkel, Vice Chairman of American International Group, Inc. and Harvey Krueger, Vice Chairman Emeritus of Lehman Brothers, Inc., as members of the company’s Advisory Board.